Systemic sclerosis complicated by procainamide-induced lupus and antiphospholipid syndrome.
Kameda
H
H
Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Mimori
T
T
Kaburaki
J
J
Fujii
T
T
Takahashi
T
T
Akaishi
M
M
Ikeda
Y
Y
D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D016736:Antiphospholipid Syndrome / Q000139:chemically induced* / Q000473:pathology; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D005534:Foot Diseases / Q000473:pathology; D005734:Gangrene / Q000473:pathology; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D010198:Pancytopenia / Q000139:chemically induced; D011342:Procainamide / Q000009:adverse effects*; D012595:Scleroderma, Systemic / Q000150:complications*; D013577:Syndrome; D014034:Toes / Q000473:pathology
D000889:Anti-Arrhythmia Agents; D011342:Procainamide